WHO adds GLP-1RAs to essential medicines list
The World Health Organisation (WHO) has updated its model list of essential medicines (EML) to include four key obesity and…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
-
-
Multiply Labs’ biomanufacturing robot to “slash cell therapy costs”
Multiply Labs has developed a robotic biomanufacturing cluster that the company claims can reduce the cost of cell and gene…
-
Bavarian Nordic’s Vimkunya makes UK debut amid Ixchiq suspension
Bavarian Nordic has launched its chikungunya vaccine, Vimkunya, in the UK. This follows the sharp rise in travel-related disease incidences…
-
WHO calls for mental health action as global cases reach one billion
Two reports from the World Health Organisation (WHO) have revealed that more than one billion individuals worldwide live with mental…
-
NVIDIA-backed Charm secures $80m to advance AML drug
UK-based biotech Charm Therapeutics has closed an oversubscribed Series B funding round worth $80m, which will support the progression of…
-
Teva brings first generic GLP-1 to US market with Saxenda copycat approval
Generics company Teva Pharmaceutical has obtained approval from the US Food and Drug Administration (FDA) for its generic referencing Novo…
-
Animal testing alternatives to dominate, but not overnight
In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to…
-
EU-US trade deal leaves EFPIA’s lead “concerned for the future”
Following Trump’s decision to implement 15% import tariffs on goods from the EU, the US President has signed an agreement…
-
Padcev-Keytruda combo approved for NHS use in mUC
The UK’s National Institute for Health and Care Excellence (NICE) has recommended a new combination regimen in metastatic urothelial carcinoma…
-
PTC’s vatiquinone approval hopes dashed in Friedreich’s Ataxia
The US Food and Drug Administration (FDA) has rejected PTC Therapeutics’ new drug application (NDA) for vatiquinone in Friedreich's Ataxia.…